Exploring patient and professional perspectives on implementing pharmacogenomic testing in the UK primary care setting and estimating the cost-effectiveness: a mixed-methods study protocol.

ABSTRACT:

Introduction

Pharmacogenomic testing could potentially reduce the number of adverse drug reactions and improve treatment outcomes through tailoring treatment to an individual's genetic makeup. Despite its benefits and the ambitions to integrate into routine care, the implementation of pharmacogenomic testing in primary care settings remains limited. This study aims to qualitatively explore the views of healthcare professionals (HCPs) and patients on implementing pharmacogenomic testing in the UK National Health Service (NHS) primary care setting and to estimate the cost-effectiveness of service-delivery implementation by comparing different HCPs' models of care.

Method

This study consists of three workstreams (WS). WS1 is semi-structured interviews with General Practitioners

SUBMITTER: Qureshi S 

PROVIDER: S-EPMC12306336 | biostudies-literature | 2025 Jul

REPOSITORIES: biostudies-literature